What are the DSM‑5 criteria that differentiate hypomania from mania?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DSM-5 Differentiation of Hypomania from Mania

The critical distinction between hypomania and mania in DSM-5 rests on three key factors: duration (≥4 days for hypomania versus ≥7 days for mania), severity of functional impairment (absent in hypomania, marked in mania), and hospitalization requirement (never needed for hypomania, may be required for mania). 1, 2, 3

Core Criterion A Requirements

Both hypomania and mania require the same foundational symptoms under DSM-5 Criterion A:

  • Abnormally and persistently elevated, expansive, or irritable mood PLUS abnormally and persistently increased activity or energy 1, 2, 4
  • This represents a critical change from DSM-IV, where increased energy/activity was optional—DSM-5 now mandates both mood change AND increased energy/activity as co-primary symptoms 4, 5, 6
  • Research demonstrates this stricter criterion reduces the prevalence of diagnosed hypomanic/manic episodes by 34%, but episodes that do meet criteria tend to be more severe 5

Duration Thresholds

Hypomania:

  • Must last at least 4 consecutive days 1, 3
  • Episodes lasting less than 4 days do not meet hypomania criteria and should be classified as Bipolar Disorder Not Otherwise Specified (NOS) 1, 3

Mania:

  • Must last at least 7 consecutive days 1, 2, 3
  • Exception: Any duration qualifies if hospitalization is required 1, 2

Functional Impairment and Severity

Hypomania:

  • Does not cause marked impairment in social or occupational functioning 1, 3
  • Does not require hospitalization 1, 3
  • Represents a noticeable change from baseline but remains manageable 1

Mania:

  • Causes marked impairment in social or occupational functioning 2
  • OR necessitates hospitalization to prevent harm to self or others 2
  • OR includes psychotic features (which automatically qualifies as mania regardless of other factors) 2, 3

Psychotic Features

  • The presence of psychotic symptoms (paranoia, hallucinations, delusions) automatically classifies the episode as mania, not hypomania 2, 3
  • Psychotic features are common in adolescent manic presentations and frequently lead to misdiagnosis as schizophrenia 1, 2

Clinical Assessment Approach

When differentiating hypomania from mania, systematically evaluate:

Episode Duration:

  • Document the exact number of consecutive days with sustained mood elevation/irritability AND increased energy/activity 1, 3
  • Use a life-charting approach to map temporal patterns 1, 3

Sleep Changes:

  • Both hypomania and mania feature decreased need for sleep without feeling tired 1, 3
  • This is a hallmark sign distinguishing true mood episodes from other conditions 3

Functional Impact Across Settings:

  • Assess whether the patient can maintain work/school performance, relationships, and daily responsibilities 1, 2
  • True mania shows impairment across multiple domains, not isolated to one setting 3

Need for Intervention:

  • Determine if hospitalization was required or considered 2
  • Evaluate whether the patient posed danger to self or others 2

Presence of Psychosis:

  • Screen for paranoia, confusion, hallucinations, or delusions 2, 3
  • Any psychotic features during a mood episode indicate mania 2, 3

Common Diagnostic Pitfalls

  • Irritability alone lacks specificity: Irritability is common across many psychiatric conditions and does not distinguish hypomania from mania—focus on the constellation of symptoms, duration, and impairment 1, 3
  • Chronic baseline irritability is not hypomania: Episodes must represent a significant departure from baseline functioning, not temperamental traits 1, 3
  • Antidepressant-induced symptoms: Manic or hypomanic symptoms precipitated by antidepressants should be classified as substance-induced per DSM-5 2, 3
  • Pediatric presentations differ: Children and adolescents show more irritability, mixed states, and rapid cycling compared to adults, complicating the distinction 1, 3
  • High comorbidity in youth: ADHD and disruptive behavior disorders frequently co-occur with bipolar disorder in children, requiring careful differentiation of chronic overactivity from episodic mood elevation 1, 3

Special Considerations in Children and Adolescents

  • Youth often present with greater mood lability, mixed affective states, and rapid cycling that differ from classic adult presentations 1, 3
  • Distinguish hallmark hypomanic/manic features from normative childhood behaviors such as boastful play, imaginative scenarios, typical overactivity, and age-appropriate risk-taking 3
  • Adolescent mania frequently includes psychotic features and is often misdiagnosed as schizophrenia—confirm the episodic nature with clear periods of normal functioning between episodes 1, 2

Impact of DSM-5 Changes

  • The addition of increased energy/activity as a mandatory co-primary symptom reduces the number of diagnosed hypomanic/manic episodes but identifies more severe cases 4, 5, 6
  • Real-world smartphone-based daily assessments show that co-occurring elevated/irritable mood with increased activity occurs only 0.12% of the time for four consecutive days, compared to 24% for mood changes alone 7
  • This stricter criterion may prevent overdiagnosis of bipolar disorder but risks underdiagnosing clinically significant hypomanic episodes 5, 6

References

Guideline

DSM Criteria for Diagnosing Bipolar Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Criteria for Mania

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bipolar Disorder Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Bipolar disorders in DSM-5: strengths, problems and perspectives.

International journal of bipolar disorders, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.